XML 62 R14.htm IDEA: XBRL DOCUMENT v2.4.1.9
Financial Instruments
3 Months Ended
Mar. 31, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Financial Instruments
8. Financial Instruments

We do not enter into financial instruments for trading or speculative purposes. We principally use financial instruments to reduce the impact of changes in foreign currency exchange rates and commodities used as raw materials in our products. The principal derivative financial instruments we enter into on a routine basis are foreign exchange contracts. Derivative financial instruments are recorded at fair value. The counterparties to derivative contracts are major financial institutions. Management currently believes that the risk of incurring material losses is unlikely and that the losses, if any, would be immaterial to the Company. In addition, from time to time, we enter into commodity swaps.

Our primary foreign currency hedge contracts pertain to the Canadian dollar, the Mexican peso and the Chinese yuan. The gross U.S. dollar equivalent notional amount of all foreign currency derivative hedges outstanding at March 31, 2015 was $240.7 million, representing a net settlement receivable of $2.9 million. Based on foreign exchange rates as of March 31, 2015, we estimate that $2.7 million of net foreign currency derivative gains included in other comprehensive income as of March 31, 2015 will be reclassified to earnings within the next twelve months.

 

The fair values of derivative instruments on the consolidated balance sheets as of March 31, 2015 and December 31, 2014 were:

 

(In millions)         Fair Value  
    

Location

   March 31,
2015
     December 31,
2014
 

Assets

        

Foreign exchange contracts

  

Other current assets

   $ 7.6       $ 5.1   

Net investment hedges

  

Other current assets

     —           0.5   
     

 

 

    

 

 

 

Total assets

$ 7.6    $ 5.6   

Liabilities

Foreign exchange contracts

Other current liabilities

$ 4.7    $ 5.4   

The effects of derivative financial instruments on the statements of comprehensive income for the three months ended March 31, 2015 and 2014 were:

 

(In millions)         Gain Recognized in Income  

Type of hedge

  

Location

   March 31,
2015
     March 31,
2014
 

Cash flow

   Cost of products sold    $ 1.0       $ 0.7   

Fair value

   Other expense, net      1.0         0.9   
     

 

 

    

 

 

 

Total

$ 2.0    $ 1.6   

The effective portion of cash flow hedges recognized in other comprehensive income were net gains (losses) of $3.9 million and $(0.3) million at March 31, 2015 and 2014, respectively. In the three months ended March 31, 2015 and 2014, the ineffective portion of cash flow hedges recognized in other expense (income), net, was insignificant.